Search

everythinglearnresearchcommunity

for

Search:↓

Female hair loss linked to metabolic syndrome, not in males.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

17α-Estradiol solution safely improves hair density and thickness in female pattern hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

The document concludes that more research is needed to fully understand the causes of PCOS.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Antiandrogen therapy helps treat genetic hair loss.

Menopause can cause skin issues, and seeing a dermatologist helps.

Sex-determining genes may affect male baldness.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Testosterone is crucial for development, growth, and various body functions in mammals.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.